IL97638A - Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals - Google Patents
Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammalsInfo
- Publication number
- IL97638A IL97638A IL9763891A IL9763891A IL97638A IL 97638 A IL97638 A IL 97638A IL 9763891 A IL9763891 A IL 9763891A IL 9763891 A IL9763891 A IL 9763891A IL 97638 A IL97638 A IL 97638A
- Authority
- IL
- Israel
- Prior art keywords
- oxo
- dihydro
- purin
- ait
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/500,789 US5091432A (en) | 1990-03-28 | 1990-03-28 | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
IL97638A0 IL97638A0 (en) | 1992-06-21 |
IL97638A true IL97638A (en) | 1999-03-12 |
Family
ID=23990941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9763891A IL97638A (en) | 1990-03-28 | 1991-03-21 | Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals |
Country Status (17)
Country | Link |
---|---|
US (1) | US5091432A (ja) |
EP (1) | EP0522082B1 (ja) |
JP (1) | JP3198335B2 (ja) |
KR (1) | KR100194162B1 (ja) |
AT (1) | ATE154880T1 (ja) |
AU (1) | AU7678191A (ja) |
CA (1) | CA2079342C (ja) |
CS (1) | CS85991A3 (ja) |
DE (1) | DE69126701T2 (ja) |
DK (1) | DK0522082T3 (ja) |
ES (1) | ES2104700T3 (ja) |
GR (1) | GR3024904T3 (ja) |
IE (1) | IE81123B1 (ja) |
IL (1) | IL97638A (ja) |
NZ (1) | NZ237574A (ja) |
TW (1) | TW279865B (ja) |
WO (1) | WO1991014434A1 (ja) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801184A (en) * | 1994-07-25 | 1998-09-01 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US6338963B1 (en) * | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
WO1996003125A1 (en) * | 1994-07-25 | 1996-02-08 | Glasky Alvin J | Carbon monoxide dependent guanylyl cyclase modifiers |
US5447939A (en) * | 1994-07-25 | 1995-09-05 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
WO1999057120A1 (en) * | 1998-05-04 | 1999-11-11 | Neotherapeutics, Inc. | Novel serotonin-like 9-substituted hypoxanthine and methods of use |
AU3879899A (en) * | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Novel dopamine-like 9-substituted hypoxanthine and methods of use |
US6297226B1 (en) | 1999-10-15 | 2001-10-02 | Neotherapeutics, Inc. | Synthesis and methods of use of 9-substituted guanine derivatives |
US6288069B1 (en) | 1999-11-16 | 2001-09-11 | Neotherapeutics, Inc. | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
EP1537110B1 (en) * | 1999-12-06 | 2007-01-17 | Euro-Celtique, S.A. | Triazospiro compounds having nociceptin receptor affinity |
US6407237B1 (en) * | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
US6849735B1 (en) | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
WO2002004448A2 (en) * | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of drug-induced peripheral neuropathy and related conditions |
US20020128264A1 (en) * | 2000-07-07 | 2002-09-12 | Taylor Eve M. | Methods for treatment of conditions affected by activity of multidrug transporters |
US20020040031A1 (en) * | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for prevention of accumulation of amyloid beta peptide in the central nervous system |
US20020040032A1 (en) * | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for stimulation of synthesis of synaptophysin in the central nervous system |
WO2002058736A2 (en) * | 2000-12-12 | 2002-08-01 | Neotherapetics, Inc. | Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis |
US20020156277A1 (en) * | 2001-04-20 | 2002-10-24 | Fick David B. | Synthesis and methods of use of purine analogues and derivatives |
US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
US6906190B2 (en) * | 2002-01-04 | 2005-06-14 | Ribapharm Inc. | Inhibitors for de novo-RNA polymerases and methods of identifying targets for same |
CA2544573A1 (en) | 2003-11-03 | 2005-06-02 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7473728B2 (en) * | 2004-12-16 | 2009-01-06 | The Goodyear Tire & Rubber Company | Dual phase rubber composition and tire with nanocomposite-containing sidewall thereof |
WO2006085149A2 (en) | 2004-12-22 | 2006-08-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
EP1968561B8 (en) * | 2005-12-22 | 2010-10-20 | Kiacta Sàrl | Treatment of diabetic nephropathy |
DK2089417T3 (en) * | 2006-10-12 | 2015-03-23 | Bhi Ltd Partnership | Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid |
CN101730529A (zh) * | 2006-12-22 | 2010-06-09 | 贝鲁斯健康(国际)有限公司 | 用于治疗代谢疾病和糖尿病的方法、化合物和组合物 |
JP6234471B2 (ja) * | 2012-11-21 | 2017-11-22 | ゾエティス・サービシーズ・エルエルシー | スピロ環状イソキサゾリン誘導体の合成 |
CN115521306B (zh) * | 2022-09-26 | 2024-03-26 | 贵州大学 | 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3321369A (en) * | 1965-05-26 | 1967-05-23 | Abbott Lab | Method of enhancing learning rate and retention level in warm blooded animals |
US3484521A (en) * | 1966-06-23 | 1969-12-16 | Int Chem & Nuclear Corp | Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid |
US4221910A (en) * | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
US4221909A (en) * | 1978-09-15 | 1980-09-09 | Sloan-Kettering Institute For Cancer Research | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
US4221794A (en) * | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
IL64501A (en) * | 1980-12-22 | 1985-07-31 | Astra Laekemedel Ab | 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use |
US4728605A (en) * | 1984-07-31 | 1988-03-01 | Fudenberg Herman H | Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same |
US4952693A (en) * | 1984-10-12 | 1990-08-28 | Warner-Lambert Company | Oxazolo-pyrimidine derivatives |
-
1990
- 1990-03-28 US US07/500,789 patent/US5091432A/en not_active Expired - Lifetime
-
1991
- 1991-03-21 IL IL9763891A patent/IL97638A/en not_active IP Right Cessation
- 1991-03-26 AT AT91908058T patent/ATE154880T1/de not_active IP Right Cessation
- 1991-03-26 DE DE69126701T patent/DE69126701T2/de not_active Expired - Fee Related
- 1991-03-26 NZ NZ237574A patent/NZ237574A/xx unknown
- 1991-03-26 IE IE99491A patent/IE81123B1/en not_active IP Right Cessation
- 1991-03-26 EP EP91908058A patent/EP0522082B1/en not_active Expired - Lifetime
- 1991-03-26 CA CA002079342A patent/CA2079342C/en not_active Expired - Fee Related
- 1991-03-26 DK DK91908058.0T patent/DK0522082T3/da active
- 1991-03-26 WO PCT/US1991/002066 patent/WO1991014434A1/en active IP Right Grant
- 1991-03-26 KR KR1019920702359A patent/KR100194162B1/ko not_active IP Right Cessation
- 1991-03-26 ES ES91908058T patent/ES2104700T3/es not_active Expired - Lifetime
- 1991-03-26 AU AU76781/91A patent/AU7678191A/en not_active Abandoned
- 1991-03-26 JP JP50760291A patent/JP3198335B2/ja not_active Expired - Fee Related
- 1991-03-27 TW TW080102367A patent/TW279865B/zh active
- 1991-03-28 CS CS91859A patent/CS85991A3/cs unknown
-
1997
- 1997-10-01 GR GR970402551T patent/GR3024904T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05508390A (ja) | 1993-11-25 |
ES2104700T3 (es) | 1997-10-16 |
AU7678191A (en) | 1991-10-21 |
EP0522082A4 (en) | 1993-06-09 |
EP0522082B1 (en) | 1997-07-02 |
TW279865B (ja) | 1996-07-01 |
JP3198335B2 (ja) | 2001-08-13 |
IL97638A0 (en) | 1992-06-21 |
KR100194162B1 (ko) | 1999-06-15 |
WO1991014434A1 (en) | 1991-10-03 |
DE69126701T2 (de) | 1997-12-04 |
EP0522082A1 (en) | 1993-01-13 |
IE910994A1 (en) | 1991-10-09 |
DK0522082T3 (da) | 1997-07-21 |
NZ237574A (en) | 1993-09-27 |
DE69126701D1 (de) | 1997-08-07 |
ATE154880T1 (de) | 1997-07-15 |
US5091432A (en) | 1992-02-25 |
CA2079342C (en) | 2001-10-23 |
CA2079342A1 (en) | 1991-09-29 |
GR3024904T3 (en) | 1998-01-30 |
IE81123B1 (en) | 2000-03-22 |
CS85991A3 (en) | 1992-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5091432A (en) | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use | |
TWI805664B (zh) | Tlr7/8拮抗劑及其用途 | |
KR101879422B1 (ko) | Btk 및/또는 jak3 키나제의 활성을 억제하는 화합물 | |
EP2010505B1 (en) | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | |
TWI711610B (zh) | 布魯頓氏酪胺酸激酶抑制劑 | |
US11555042B2 (en) | Macrocyclic compounds as TRK kinases inhibitors | |
EP3765462B1 (en) | Substituted (2-azabicyclo [3.1.0] hexan-2-yl) pyrazolo [1, 5-a] pyrimidine and imidazo [1, 2-b] pyridazine compounds as trk kinases inhibitors | |
US20150299171A1 (en) | Inhibitors of bruton's tyrosine kinase | |
KR20080081177A (ko) | 야누스 키나아제 억제제인 술폰아미도아닐린 유도체 | |
CN101242839A (zh) | 氮杂吲唑化合物及其使用方法 | |
CN115066438A (zh) | 用于降解胞外蛋白的asgpr结合化合物 | |
JP2000515550A (ja) | サイクリン依存キナーゼ2およびIκB―αのプリン阻害剤 | |
KR20020041456A (ko) | 9-치환 구아닌 유도체의 합성 및 사용 방법 | |
US20240199623A1 (en) | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS CFTR MODULATORS | |
CN102227429B (zh) | 作为趋化因子受体调节剂的3-氨基环戊烷羧酰胺 | |
KR20190025545A (ko) | 특정 단백질 키나제 억제제 | |
RU2749038C2 (ru) | Замещенные пирроло[2,3-d]пиридазин-4-оны и пиразоло[3,4-d]пиридазин-4-оны в качестве ингибиторов протеинкиназы | |
RU2201930C2 (ru) | Применение производных теофиллина для лечения и профилактики состояний шока, новые соединения ксантина | |
US6583138B1 (en) | Heterocyclic-ring condensed benzothiazine compound | |
MXPA02004935A (es) | Uso de derivados de hipoxantina 9-sustituida para estimular la regeneracion de tejido nervioso. | |
SK24393A3 (en) | Carboxylic acid esters with 2-amino-7-(1,3-dihydroxy- -2-propoxymethyl)purine, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |